# Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers

> **NCT00172159** · PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **PROCEDURE:** Hepatic resection

## Key facts

- **NCT ID:** NCT00172159
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172159, "Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00172159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*